A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

INTRODUCTION: Subcutaneous insulin resistance syndrome (SIRS) is a rare condition in which patients poorly respond to subcutaneous (SC) insulin but maintain a normal response to intravenous (IV) insulin. The underlying pathophysiology remains elusive. Several treatment regimens have been tested for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweis, Nabil W. G., Albanna, Ahmad, Alhasoun, Rama, Zayed, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661541/
https://www.ncbi.nlm.nih.gov/pubmed/36407033
http://dx.doi.org/10.5812/ijem-126350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661541/
https://www.ncbi.nlm.nih.gov/pubmed/36407033
http://dx.doi.org/10.5812/ijem-126350

Ejemplares similares